AwardedSpainGoods
Suministro del principio activo denominado SACITUZUMAB GOVITECAN 200 MG VIAL POLVO PERFUSION para el Servicio de Farmacia delComplejo Hospitalario Universitario de Canarias.
- Published
- Published 23 October 2025
Overview
Suministro del principio activo denominado SACITUZUMAB GOVITECAN 200 mg vial en polvo para perfusión para el Servicio de Farmaciadel Complejo Hospitalario Universitario de Canarias con la finalidad de atender las necesidades derivadas de la actividad habitual de este Centro Sanitario.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 23 October 2025
Various medicinal products
Award outcome
- Awarded value
- €614,141
- Award date
- 11 September 2025
- GILEAD SCIENCES, S.L.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
23 October 2025
Contracting authority
Dirección Gerencia del Complejo Hospitalario Universitario de Canarias
Procuring entitySanta Cruz de Tenerife, Spain
ID_PLATAFORMA: 21063730150133
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.